Shenzhen Edge Medical (2675) Stock Overview

Engages in designing, developing, manufacturing, and sale of surgical robots in Europe, and China. More details

2675 fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	5/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 42.1% below our estimate of its fair value

Earnings are forecast to grow 87.86% per year

Revenue grew by 184.8% over the past year

Analysts in good agreement that stock price will rise by 49.8%

Risk Analysis

No risks detected for 2675 from our risk checks.

2675 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Shenzhen Edge Medical Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Shenzhen Edge Medical
Historical stock prices
Current Share Price	HK$53.95
52 Week High	HK$73.70
52 Week Low	HK$48.00
Beta	0
1 Month Change	2.37%
3 Month Change	-11.56%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-4.68%

Recent updates

Shareholder Returns

	2675	HK Medical Equipment	HK Market
7D	1.2%	-4.5%	-1.6%
1Y	n/a	2.5%	10.4%

Return vs Industry: Insufficient data to determine how 2675 performed against the Hong Kong Medical Equipment industry.

Return vs Market: Insufficient data to determine how 2675 performed against the Hong Kong Market.

Price Volatility

Is 2675's price volatile compared to industry and market?
2675 volatility
2675 Average Weekly Movement	7.4%
Medical Equipment Industry Average Movement	7.1%
Market Average Movement	7.4%
10% most volatile stocks in HK Market	15.6%
10% least volatile stocks in HK Market	3.6%

Stable Share Price: 2675 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: Insufficient data to determine 2675's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2017	602	Jianchen Wang	www.edgemed.cn

Shenzhen Edge Medical Co., Ltd. engages in designing, developing, manufacturing, and sale of surgical robots in Europe, and China. The company focus on surgical robots and instruments for minimally invasive surgery or MIS, including multi-port endoscopic surgical robots and single-port endoscopic surgical robots. Its products include Edge Multi-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS using robotic, imaging, and digital technologies; Edge Single-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS through a single small incision or natural orifice; Edge Cloud Telesurgery System; and Edge Bronchoscope Robot.

Shenzhen Edge Medical Co., Ltd. Fundamentals Summary

How do Shenzhen Edge Medical's earnings and revenue compare to its market cap?
2675 fundamental statistics
Market cap	HK$21.16b
Earnings (TTM)	-HK$102.63m
Revenue (TTM)	HK$527.83m

40.1x

P/S Ratio

-206.0x

P/E Ratio

Is 2675 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2675 income statement (TTM)
Revenue	CN¥455.72m
Cost of Revenue	CN¥155.06m
Gross Profit	CN¥300.65m
Other Expenses	CN¥389.26m
Earnings	-CN¥88.61m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.23
Gross Margin	65.97%
Net Profit Margin	-19.44%
Debt/Equity Ratio	0%

How did 2675 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/01 16:41
End of Day Share Price	2026/06/01 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shenzhen Edge Medical Co., Ltd. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Zhu Chen	Citic Securities Co., Ltd.
Nico Chen	DBS Bank Ltd
Yinglong Pan	Goldman Sachs

Shenzhen Edge Medical Co., Ltd.SEHK:2675 Stock Report